Prostate cancer is the most commonly diagnosed cancer in men. In the August 23 Nature, Saravana Dhanasekaran and colleagues from the University of Michigan Medical School describe the use of cDNA ...
Researchers found that analyzing certain chemokine levels may help explain racial disparities in prostate cancer lethality, and that neutralizing such chemokines could potentially benefit prostate ...
The precise identification of tumor boundaries during radical prostatectomy remains a major clinical challenge. As positive ...
Explicit Prognostic Information and Reassurance About Nonabandonment When Entering Palliative Breast Cancer Care: Findings From a Scripted Video-Vignette Study Microarray-based screening and bisulfite ...
In 1997, Juha Kononen, a postdoctoral fellow at the National Human Genome Research Institute, was pondering the significance of the recently developed DNA microarray. He was studying genetically ...
STATEN ISLAND, N.Y. — Northwell Staten Island University Hospital (SIUH) has announced the addition of a new, non-invasive treatment for localized prostate cancer, which provides precision in ...
Accurate classification of tissue samples is an essential tool in disease diagnosis and treatment. The DNA microarray technology enables disease classification based only on gene expression analysis, ...
LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback